We are live on ! Find out more
AIM

ARK Investment Management Portfolio holdings

AUM $12.9B
1-Year Est. Return 64.92%
 

ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.

This Fund
S&P 500
This Quarter Est. Return
+5.33%
1 Year Est. Return
+64.92%
3 Year Est. Return
+195.95%
5 Year Est. Return
+58.35%
10 Year Est. Return
AUM
$1.26B
AUM Growth
+$436M
Cap. Flow
+$434M
Cap. Flow %
34.56%
Top 10 Hldgs %
33.6%
Holding
211
New
66
Increased
116
Reduced
15
Closed
11

Top Buys

Rank Stock Value
1
SSYS icon
Stratasys
SSYS
+$26.2M
2
JD icon
JD.com
JD
+$25.8M
3
TSLA icon
Tesla
TSLA
+$25.3M
4
NTLA icon
Intellia Therapeutics
NTLA
+$23.1M
5
HAPN
Happen Inc
HAPN
+$18.1M

Top Sells

Rank Stock Value
1
AKAM icon
Akamai
AKAM
+$6.48M
2
BB icon
BlackBerry
BB
+$4.55M
3
TWLO icon
Twilio
TWLO
+$3.67M
4
TMO icon
Thermo Fisher Scientific
TMO
+$3.58M
5
FMI
Foundation Medicine, Inc.
FMI
+$2.76M

Sector Composition

Rank Sector Weight
1 Technology 24.34%
2 Healthcare 19.56%
3 Communication Services 14.61%
4 Consumer Discretionary 14.22%
5 Industrials 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URGN icon
101
UroGen Pharma
URGN
$1.88B
$345K 0.03%
+9,284
New +$331K
TEVA icon
102
Teva Pharmaceuticals
TEVA
$40.2B
$325K 0.03%
+17,164
New +$258K
SEDG icon
103
SolarEdge
SEDG
$2.74B
$315K 0.03%
+8,382
New +$289K
CALL
104
DELISTED
magicJack VocalTec Ltd
CALL
$314K 0.03%
+37,211
New +$282K
NTBL
105
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$302K 0.02%
+1,214
New +$282K
ORBK
106
DELISTED
Orbotech Ltd
ORBK
$293K 0.02%
+5,832
New +$284K
GILT icon
107
Gilat Satellite Networks
GILT
$883M
$290K 0.02%
+36,694
New +$264K
RDWR icon
108
Radware
RDWR
$1.16B
$288K 0.02%
+14,835
New +$281K
NICE icon
109
Nice
NICE
$5.9B
$287K 0.02%
+3,126
New +$266K
PNTR
110
DELISTED
Pointer Telocation Ltd.
PNTR
$279K 0.02%
+15,002
New +$263K
TSEM icon
111
Tower Semiconductor
TSEM
$26.5B
$278K 0.02%
+8,162
New +$271K
CEL
112
DELISTED
Cellcom Israel, Ltd.
CEL
$272K 0.02%
+26,332
New +$255K
ALNY icon
113
Alnylam Pharmaceuticals
ALNY
$29.5B
$267K 0.02%
2,098
-6,976
-77% -$877K
SILC icon
114
Silicom
SILC
$237M
$262K 0.02%
+3,742
New +$256K
CAMT icon
115
Camtek
CAMT
$6.52B
$259K 0.02%
+45,300
New +$262K
KMDA icon
116
Kamada
KMDA
$417M
$251K 0.02%
+52,695
New +$248K
RDCM icon
117
Radcom
RDCM
$169M
$248K 0.02%
+12,470
New +$254K
TARO
118
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$247K 0.02%
+2,356
New +$259K
CRNT icon
119
Ceragon Networks
CRNT
$200M
$245K 0.02%
+123,737
New +$244K
MGIC
120
DELISTED
Magic Software Enterprises
MGIC
$242K 0.02%
+28,561
New +$247K
CYBR
121
DELISTED
CyberArk
CYBR
$240K 0.02%
+5,810
New +$254K
FOMX
122
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$235K 0.02%
+39,160
New +$236K
ITRN icon
123
Ituran Location and Control
ITRN
$1.1B
$233K 0.02%
+6,802
New +$243K
AUDC icon
124
AudioCodes
AUDC
$249M
$227K 0.02%
+30,895
New +$222K
RADA
125
DELISTED
Rada Electronic Industries Ltd
RADA
$225K 0.02%
+73,042
New +$239K

Similar funds

ARK Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, ARK Investment Management held 211 positions worth $1.26B, up 53% from $819M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ARK Investment Management deployed $434M of net new capital in Q4 2017, opening 66 new positions and adding to 116 existing holdings. Its largest new stake was Cognex: 17,948 shares worth $1.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Akamai, an estimated $6.48M trimmed.

  • ARK Investment Management's largest Q4 2017 buy was Cognex: 17,948 shares worth $1.1M.
  • ARK Investment Management added most to Stratasys in Q4 2017, an estimated $26.2M increase.
  • ARK Investment Management's biggest Q4 2017 reduction was Akamai, cutting an estimated $6.48M.
  • ARK Investment Management fully exited Thermo Fisher Scientific in Q4 2017, selling an estimated $3.58M.
  • ARK Investment Management's ten largest holdings make up 34% of its $1.26B portfolio in Q4 2017.
  • ARK Investment Management opened 66 new positions and closed 11 in Q4 2017.
  • ARK Investment Management's portfolio value rose 53% quarter-over-quarter to $1.26B.

Based on ARK Investment Management's 13F filing for Q4 2017, filed 12 Feb 2018.